Walmart boosts pharmacy pay, elevates 3,000 roles in healthcare push
Jan 28 (Reuters) – U.S. retailer Walmart (WMT.O), opens new tab on Wednesday said it has elevated 3,000…
Many patients may keep off lost pounds after stopping a GLP-1, US data suggests
Real-world data suggests weight loss durability post-GLP-1 drug discontinuation Study suggests weight regain may be less common than…
Global bond markets shaken by Japan selloff, Greenland worries
Japanese bond selloff spills over globally Long-dated U.S. yields post biggest two-day rise since May Greenland tensions add…
Danish pension fund to divest its U.S. Treasuries
COPENHAGEN, Jan 20 (Reuters) – Danish pension fund AkademikerPension said on Tuesday it would sell off its holding…
Italy updates Arctic stance as Greenland tensions escalate
ROME, Jan 16 (Reuters) – The Arctic has become a theatre of intensifying strategic rivalry, an Italian government…
US FDA requests removal of suicide warnings from weight-loss drug labels
Jan 13 (Reuters) – The U.S. health regulator asked drugmakers on Tuesday to remove label warnings about a…
Maersk explores more ethanol use for green fuel to cut reliance on China, FT reports
Jan 11 (Reuters) – Danish shipping company Maersk (MAERSKb.CO), opens new tab is looking at increasing its use…
India’s water crunch brews risks for beverage giants
ALWAR, India, Dec 26 (Reuters) – Foreign companies operating in India have long grappled with complex regulations and…
European shares close at fresh record high as Novo Nordisk drives healthcare boost
Euro zone equity volatility at over a year-low Healthcare stocks top gainers after Novo Nordisk boost Basic resources…
Lawsuits claiming Ozempic, other GLP-1s led to blindness become second mass litigation over the drugs
DEC 15 (Reuters) – A federal judicial panel said Monday it would centralize a growing number of lawsuits…
Undeterred by Novo Nordisk failure, scientists consider GLP-1s as Alzheimer’s prevention
More trials needed testing the drugs in people at risk of dementia, scientists say Diabetes patients on GLP-1s…
US slashes 36% off Medicare spending on 15 high-priced medicines
Medicare says negotiated prices for 15 drugs to cut spending by 36% New prices to take effect in…